Analysis of blood RNA expression and antigen-specific PBMC profiles during the two-dose M72/AS01E regimen has revealed that this TB vaccine induces CD4+ T cells and multifunctional T cells after stimulation, although no IL-17A was detected. This evidence concerns the gene CD4 and tuberculosis.